Provista Blog > 6 Types of Biomarkers in Cancer Detection
There are several types of biomarkers, which fulfill different roles across the continuum of care. By analyzing biomarkers, diagnostic tests may be able to provide information about early tumor development to detect breast cancer at an early, more treatable stage. These biomarkers can be helpful in managing patients in the following settings:
Videssa® Breast is a diagnostic test for breast cancer detection and is not recommended for screening. Oncotype Dx is a registered trademark of Genomic Health, Inc. and Mammaprint is a registered trademark of Agendia, Inc.
By using different types of biomarkers in cancer detection that are specifically geared towards breast cancer, another biological view of current disease state is available in addition to the anatomical view of breast imaging. Types of cancer biomarkers are capable of detecting, predicting and diagnosing disease. These biomarkers can also assist in personalized prognosis and treatment strategies as well as recurring monitoring for the disease.
To learn more about the role different types of biomarkers play in cancer detection, read our guide below:
At Provista Diagnostics, our mission is to develop world-class diagnostic tests for indications in breast and gynecologic cancers. As a leading diagnostics company, our aim is to create, produce and market innovative solutions for unmet clinical needs. Our products and services help to diagnose diseases and inform better clinical decisions, thus enhancing women’s health and quality of life. We do this in a responsible and ethical manner with a commitment to excellence in every aspect of our business.